Showing results (91-100 of 690) with videos related to

Sort By:
Pageof 69
Science Translational Medicine|July 29, 2026
Glioblastoma: Overcoming fundamental biological and delivery barriers to therapyGenaro R Villa, Ashish D Patel, David A Reardon, et al.
Multiple Sclerosis and Related Disorders|June 21, 2022
Spatial distribution of multiple sclerosis iron rim lesions and their impact on disabilityMatthias Wittayer, Claudia E Weber, Michael Platten, et al.
Discovery Medicine|July 16, 2015
One size should not fit all: advancing toward personalized glioblastoma therapyDavid A Reardon, Keith L Ligon, E Antonio Chiocca, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2006
Recent advances in the treatment of malignant astrocytomaDavid A Reardon, Jeremy N Rich, Henry S Friedman, et al.
Expert Review of Neurotherapeutics|April 3, 2013
Current and future directions for Phase II trials in high-grade gliomaBrian M Alexander, Eudocia Q Lee, David A Reardon, et al.
European Archives of Psychiatry and Clinical Neuroscience|June 11, 2020
Decreased utilization of mental health emergency service during the COVID-19 pandemicCarolin Hoyer, Anne Ebert, Kristina Szabo, et al.
Histopathology|November 19, 2011
Human epidermal growth factor receptor 2 testing in gastric carcinoma: issues related to heterogeneity in biopsies and resectionsStephen Lee, Willem Bastiaan de Boer, Soraya Fermoyle, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 2, 2022
Impact of disease-modifying therapies on evolving tissue damage in iron rim multiple sclerosis lesionsPhilipp Eisele, Matthias Wittayer, Claudia E Weber, et al.
RMD Open|September 8, 2017
Fully automated joint space width measurement and digital X-ray radiogrammetry in early RAMichael Platten, Yogan Kisten, Johan Kälvesten, et al.
Pageof 69